Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab-Reference-Cited by-同舟云学术

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab

Published:2022-09-24 Issue:12 Volume:113 Page:4059-4069
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Takahashi Shuhei¹^ORCID,Narita Shintaro¹^ORCID,Fujiyama Nobuhiro²,Hatakeyama Shingo³,Kobayashi Takashi⁴^ORCID,Kato Renpei⁵,Naito Sei⁶,Sakatani Toru⁴,Kashima Soki¹,Koizumi Atsushi¹,Yamamoto Ryohei¹,Nara Taketoshi¹,Kanda Souhei¹,Numakura Kazuyuki¹,Saito Mitsuru¹,Obara Wataru⁵^ORCID,Tsuchiya Norihiko⁶,Ohyama Chikara³,Ogawa Osamu⁴^ORCID,Habuchi Tomonori¹

Affiliation:

1. Department of Urology Akita University School of Medicine Akita Japan

2. Clinical Research Support Center Akita University Hospital Akita Japan

3. Department of Urology Hirosaki University School of Medicine Hirosaki Japan

4. Department of Urology Kyoto University Graduate School of Medicine Kyoto Japan

5. Department of Urology Iwate Medical School of Medicine Iwate Japan

6. Department of Urology Yamagata University Faculty of Medicine Yamagata Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject